|
Delaware
(State or other jurisdiction
of incorporation or organization) |
| |
26-3632015
(I.R.S. Employer
Identification Number) |
|
|
Large accelerated filer
☒
|
| |
Smaller reporting company
☐
|
|
|
Accelerated filer
☐
|
| |
Emerging growth company
☐
|
|
|
Non-accelerated filer
☐
|
| | | |
| | | | | 1 | | | |
| | | | | 2 | | | |
| | | | | 3 | | | |
| | | | | 4 | | | |
| | | | | 5 | | | |
| | | | | 7 | | | |
| | | | | 8 | | | |
| | | | | 9 | | | |
| | | | | 10 | | | |
| | | | | 17 | | | |
| | | | | 24 | | | |
| | | | | 25 | | | |
| | | | | 26 | | | |
| | | | | 29 | | | |
| | | | | 29 | | |
|
SEC registration fee
|
| | | $ | (1) | | |
|
FINRA filing fee
|
| | |
|
(1)
|
| |
|
Accounting fees and expenses
|
| | |
|
(1)
|
| |
|
Legal fees and expenses
|
| | |
|
(1)
|
| |
|
Transfer agent’s, trustee’s and depositary’s fees and expenses
|
| | |
|
(1)
|
| |
|
Printing fees and expenses
|
| | |
|
(1)
|
| |
|
Miscellaneous
|
| | |
|
(1)
|
| |
|
Total
|
| | | $ | (1) | | |
| | | | | | | | | |
Incorporated by Reference
|
| | | | ||||||
Exhibit
Number |
| |
Description of Exhibit
|
| |
Form
|
| |
File No.
|
| |
Exhibit
Number |
| |
Filing Date
|
| ||||
| | 1.1 | | | | Form of Underwriting Agreement | | | | | | | | | | | |
*
|
| |
| | 1.2 | | | | | |
10-K
|
| |
001-37359
|
| |
1.1.
|
| |
February 17, 2022
|
| ||
| | 3.1 | | | | | |
10-Q
|
| |
001-37359
|
| |
3.1
|
| |
November 9, 2015
|
| ||
| | 3.2 | | | | | |
8-K
|
| |
001-37359
|
| |
3.1
|
| |
December 6, 2022
|
| ||
| | 4.1 | | | | | | | | | | | | | | |
Filed herewith.
|
| ||
| | 4.2 | | | | | | | | | | | | | | |
Filed herewith.
|
| ||
| | 4.3 | | | | Form of Warrant Agreement | | | | | | | | | | | |
*
|
| |
| | 4.4 | | | | Form of Purchase Contract Agreement | | | | | | | | | | | |
*
|
| |
| | 4.5 | | | | Form of Unit Agreement | | | | | | | | | | | |
*
|
| |
| | 5.1 | | | | | | | | | | | | | | |
Filed herewith.
|
| ||
| | 23.1 | | | | | | | | | | | | | | |
Filed herewith.
|
| ||
| | 23.2 | | | | | | | | | | | | | | |
Filed herewith.
|
| ||
| | 24.1 | | | | | | | | | | | | | | |
Filed herewith.
|
| ||
| | 25.1 | | | |
The Statement of Eligibility on
Form T-1 under the Trust Indenture Act of 1939, as amended, of the Trustee under the Senior Indenture |
| | | | | | | | | | |
**
|
| |
| | 25.2 | | | |
The Statement of Eligibility on
Form T-1 under the Trust Indenture Act of 1939, as amended, of the Trustee under the Subordinated Indenture |
| | | | | | | | | | |
**
|
| |
| | 107 | | | | | | | | | | | | | | |
Filed herewith.
|
|
| | | | BLUEPRINT MEDICINES CORPORATION | | | | |
| | | |
By:
/s/ Kathryn Haviland
Kathryn Haviland
President and Chief Executive Officer |
| |
|
Signature
|
| |
Title
|
| |
Date
|
|
|
/s/ Kathryn Haviland
Kathryn Haviland
|
| | President, Chief Executive Officer and Director (Principal Executive Officer) | | |
February 17, 2023
|
|
|
/s/ Michael Landsittel
Michael Landsittel
|
| |
Chief Financial Officer
(Principal Financial Officer) |
| |
February 17, 2023
|
|
|
/s/ Ariel Hurley
Ariel Hurley
|
| |
Senior Vice President, Finance
(Principal Accounting Officer) |
| |
February 17, 2023
|
|
|
/s/ Jeffrey W. Albers
Jeffrey W. Albers
|
| | Chairman of the Board of Directors | | |
February 17, 2023
|
|
|
/s/ Daniella Beckman
Daniella Beckman
|
| | Director | | |
February 17, 2023
|
|
|
/s/ Alexis Borisy
Alexis Borisy
|
| | Director | | |
February 17, 2023
|
|
|
/s/ Lonnel Coats
Lonnel Coats
|
| | Director | | |
February 17, 2023
|
|
|
Signature
|
| |
Title
|
| |
Date
|
|
|
/s/ Habib Dable
Habib Dable
|
| | Director | | |
February 17, 2023
|
|
|
/s/ Mark Goldberg
Mark Goldberg, M.D.
|
| | Director | | |
February 17, 2023
|
|
|
/s/ Nicholas Lydon
Nicholas Lydon, Ph.D.
|
| | Director | | |
February 17, 2023
|
|
|
/s/ Lynn Seely
Lynn Seely, M.D.
|
| | Director | | |
February 17, 2023
|
|
|
/s/ John Tsai
John Tsai, M.D.
|
| | Director | | |
February 17, 2023
|
|